Through her clinical and translational research efforts, Carrie Lubitz, MD, MPH, is influencing thyroid cancer care across the world.
Dr. Lubitz has placed a high priority on prediction and decision-analytic modeling. This, in turn, has helped to assess the comparative effectiveness and improve the quality of care of patients with endocrine-related disorders. Her focus on this area is exceedingly important, as it underscores the need for cancer care to be closely aligned with the specific needs of each patient.
Dr. Lubitz has received a number of accolades for her work and is a current recipient of a K07 NIH young-investigator award, Claflin Distinguished Scholar Award, and an ATA/ThyCa Research Grant. She has mentored numerous budding surgeons and researchers, and has published and presented widely, both nationally and internationally. Dr. Lubitz is an assistant professor of Surgery at Harvard Medical School and a member of the Endocrine Surgery Unit at Mass General.
Her colleague, Rajshri Mainthia, MD, says that Dr. Lubitz “stands out as one of the biggest patients advocates, and is frankly the most dedicated and inspirational person I know. She also happens to be an incredible role model as a female surgeon-scientist who consistently ‘lifts as she rises.’”
